LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

Home・Aandelen Lijst・Avita Therapeutics Inc

Avita Therapeutics Inc

Gesloten

4.93 2.28

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

4.7

Max

5.04

Belangrijke statistieken
By Trading Economics
Inkomsten	1.6M -12M
Verkoop	554K 18M
EPS	-0.536
Winstmarge	-65.968
Werknemers	226
EBITDA	1.6M -9.7M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	-6.44% downside

Dividenden
By Dow Jones
Volgende Winsten	7 mei 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	38M 161M
Vorige openingsprijs	2.65
Vorige sluitingsprijs	4.93

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

8.83 / 9.77 Steun & Weerstand

Avita Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

4 mrt 2026, 23:39 UTC

Populaire aandelen

Stocks to Watch: Broadcom, StubHub, PepGen, Veeva Systems

4 mrt 2026, 23:20 UTC

Winsten

Broadcom Sales Rise as AI Developers Build More Products and Agents -- Update

4 mrt 2026, 21:43 UTC

Winsten

Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback Amid Climbing AI Demand

4 mrt 2026, 23:48 UTC

Marktinformatie

Nikkei May Rise After Recent Selloffs -- Market Talk

4 mrt 2026, 23:33 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Gold Edges Higher Amid Ongoing U.S.-Iran Conflict -- Market Talk

4 mrt 2026, 23:24 UTC

Marktinformatie

RBA on Track to Raise Rates, but What's the Rush? -- Market Talk

4 mrt 2026, 22:30 UTC

Winsten

Ecopetrol: Distribution Equivalent to a Payout of 50.1% of Ecopetrol S.A.'s Net Income in 2025 >EC

4 mrt 2026, 22:30 UTC

Winsten

Ecopetrol: Payment of Dividends Proposed to Be Made No Later Than April 30 >EC

4 mrt 2026, 22:30 UTC

Winsten

Ecopetrol: Earnings Distribution Proposes Ordinary Div Distribution of COP110 per Shr >EC

4 mrt 2026, 22:13 UTC

Winsten

Vermilion Energy: Expects Full-Yr Production of 118,000 to 122,000 Boe/d (70% Natural Gas) >VET

4 mrt 2026, 22:13 UTC

Winsten

Vermilion Energy: Expects 1Q Production to Avg 122,000 to 124,000 Boe/d (70% Natural Gas) >VET

4 mrt 2026, 22:13 UTC

Winsten

Vermilion Energy 4Q EPS C$2.86 >VET

4 mrt 2026, 22:04 UTC

Marktinformatie

RBA Slipping Behind The Curve On Rates -- Market Talk

4 mrt 2026, 21:53 UTC

Winsten

Lithium Americas 4Q Rev $66.8M >LAC

4 mrt 2026, 21:53 UTC

Winsten

Lithium Americas 4Q Loss/Shr 52c >LAC

4 mrt 2026, 21:52 UTC

Winsten

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mrt 2026, 21:50 UTC

Winsten

These Stocks Are Today's Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More -- Barrons.com

4 mrt 2026, 21:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

4 mrt 2026, 21:48 UTC

Winsten

Webull 4Q Rev $165.2M >BULL

4 mrt 2026, 21:48 UTC

Winsten

Webull 4Q EPS 1c >BULL

4 mrt 2026, 21:45 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

4 mrt 2026, 21:45 UTC

Marktinformatie

Canada Officials Might Need to Intervene to Spur Home Building -- Market Talk

4 mrt 2026, 21:40 UTC

Winsten

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mrt 2026, 21:36 UTC

Belangrijke Nieuwsgebeurtenissen

Iran Conflict Spurs Rebound in U.S. Borrowing Costs -- Update

4 mrt 2026, 21:27 UTC

Winsten

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mrt 2026, 21:17 UTC

Marktinformatie

Energy Price Volatility Boosts Case for Climate-Tech Startups -- Market Talk

4 mrt 2026, 21:16 UTC

Winsten

Broadcom: Board Authorizes Share-Repurchase Program for Up to $10B of Common Stock >AVGO

4 mrt 2026, 21:15 UTC

Winsten

Broadcom 1Q EPS $1.50 >AVGO

4 mrt 2026, 21:15 UTC

Winsten

Broadcom 1Q Net $7.35B >AVGO

4 mrt 2026, 21:15 UTC

Winsten

Broadcom 1Q Rev $19.31B >AVGO

Peer Vergelijking

Prijswijziging

Avita Therapeutics Inc Prognose

Koersdoel

By TipRanks

-6.44% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 4.5 USD -6.44%

Hoogste 5.5 USD

Laagste 3.5 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Avita Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

3 ratings

Buy

Hold

Sell

Gebaseerd op 3 analisten die aandelenratings hebben gegeven aan Avita Therapeutics Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

8.83 / 9.77Steun & Weerstand

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.